MyFinsight
Home
Compare
About
Recent SEC Filings
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/9
MICRON TECHNOLOGY INC
(MU)
10/9
DELTA AIR LINES, INC.
(DAL)
10/8
PEPSICO INC
(PEP)
10/8
LEVI STRAUSS & CO
(LEVI)
10/8
CONSTELLATION BRANDS, INC.
(STZ)
10/8
CINTAS CORP
(CTAS)
10/6
Lamb Weston Holdings, Inc.
(LW)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$3,772,008
EPS
-$2.75
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
Research and development
503,020
182,147
General and administrative
3,285,481
703,444
Depreciation
1,159
1,159
Total operating expenses
3,789,660
886,750
Loss from operations
-3,789,660
-886,750
Interest income
28,285
1,078
Interest expense
10,633
38,219
Other income
-
600
Total other income (expense), net
17,652
-36,541
Net loss
-3,772,008
-923,291
Basic EPS
-2.75
-0.2
Diluted EPS
-2.75
-0.2
Basic Average Shares
1,419,767
6,995,469
Diluted Average Shares
1,419,767
6,995,469
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
LABT Income Statement Sankey Diagram
Sankey diagram visualizing LABT income statement for the period
Interest income
$28,285
Net loss
-$3,772,008
Total other income
(expense), net
$17,652
Interest expense
$10,633
Loss from operations
-$3,789,660
Total operating
expenses
$3,789,660
General and
administrative
$3,285,481
Research and development
$503,020
Depreciation
$1,159
Buy us a coffee
Lakewood-Amedex Biotherapeutics Inc. (LABT)
Lakewood-Amedex Biotherapeutics Inc. (LABT)